Selected research
Market Outlook & Growth Opportunities
Global Isosorbide Mononitrate Market Outlook and Growth Opportunities 2026
Market perspective
The global Isosorbide Mononitrate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Isosorbide Mononitrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Isosorbide Mononitrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Isosorbide Mononitrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Isosorbide Mononitrate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Isosorbide Mononitrate market include Teva, Shandong Fangming Pharmaceutical Group, Sandoz, ReYoung Pharmaceutical, Merck, Taj pharmaceutical, Nesher Pharmaceuticals, Intas Pharmaceuticals and Intas Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Isosorbide Mononitrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Isosorbide Mononitrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Isosorbide Mononitrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isosorbide Mononitrate market size, projected growth trends, production technologies, key applications, and end-use industries.
Isosorbide Mononitrate Segment by Company
Teva
Shandong Fangming Pharmaceutical Group
Sandoz
ReYoung Pharmaceutical
Merck
Taj pharmaceutical
Nesher Pharmaceuticals
Intas Pharmaceuticals
Intas Pharmaceuticals
Globus Remedies
AMRI
Isosorbide Mononitrate Segment by Type
10 mg Tablet
20 mg Tablet
Isosorbide Mononitrate Segment by Application
Treatment of Angina Pectoris
Others
Isosorbide Mononitrate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Isosorbide Mononitrate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Isosorbide Mononitrate market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Isosorbide Mononitrate significant trends, drivers, influence factors in global and regions.
6. To analyze Isosorbide Mononitrate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isosorbide Mononitrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Isosorbide Mononitrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isosorbide Mononitrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Isosorbide Mononitrate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isosorbide Mononitrate industry.
Chapter 3: Detailed analysis of Isosorbide Mononitrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Isosorbide Mononitrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Isosorbide Mononitrate in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 10 mg Tablet
- 20 mg Tablet
Applications
- Treatment of Angina Pectoris
- Others
Companies covered
- Teva
- Shandong Fangming Pharmaceutical Group
- Sandoz
- ReYoung Pharmaceutical
- Merck
- Taj pharmaceutical
- Nesher Pharmaceuticals
- Intas Pharmaceuticals
- Intas Pharmaceuticals
- Globus Remedies
- AMRI
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Isosorbide Mononitrate Sales Value (2021-2032)
- 1.2.2 Global Isosorbide Mononitrate Sales Volume (2021-2032)
- 1.2.3 Global Isosorbide Mononitrate Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Isosorbide Mononitrate Market Dynamics
- 2.1 Isosorbide Mononitrate Industry Trends
- 2.2 Isosorbide Mononitrate Industry Drivers
- 2.3 Isosorbide Mononitrate Industry Opportunities and Challenges
- 2.4 Isosorbide Mononitrate Industry Restraints
3 Isosorbide Mononitrate Market by Company
- 3.1 Global Isosorbide Mononitrate Company Revenue Ranking in 2025
- 3.2 Global Isosorbide Mononitrate Revenue by Company (2021-2026)
- 3.3 Global Isosorbide Mononitrate Sales Volume by Company (2021-2026)
- 3.4 Global Isosorbide Mononitrate Average Price by Company (2021-2026)
- 3.5 Global Isosorbide Mononitrate Company Ranking (2024-2026)
- 3.6 Global Isosorbide Mononitrate Company Manufacturing Base and Headquarters
- 3.7 Global Isosorbide Mononitrate Company Product Type and Application
- 3.8 Global Isosorbide Mononitrate Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Isosorbide Mononitrate Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Isosorbide Mononitrate Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Isosorbide Mononitrate Market by Type
- 4.1 Isosorbide Mononitrate Type Introduction
- 4.1.1 10 mg Tablet
- 4.1.2 20 mg Tablet
- 4.2 Global Isosorbide Mononitrate Sales Volume by Type
- 4.2.1 Global Isosorbide Mononitrate Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Isosorbide Mononitrate Sales Volume by Type (2021-2032)
- 4.2.3 Global Isosorbide Mononitrate Sales Volume Share by Type (2021-2032)
- 4.3 Global Isosorbide Mononitrate Sales Value by Type
- 4.3.1 Global Isosorbide Mononitrate Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Isosorbide Mononitrate Sales Value by Type (2021-2032)
- 4.3.3 Global Isosorbide Mononitrate Sales Value Share by Type (2021-2032)
5 Isosorbide Mononitrate Market by Application
- 5.1 Isosorbide Mononitrate Application Introduction
- 5.1.1 Treatment of Angina Pectoris
- 5.1.2 Others
- 5.2 Global Isosorbide Mononitrate Sales Volume by Application
- 5.2.1 Global Isosorbide Mononitrate Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Isosorbide Mononitrate Sales Volume by Application (2021-2032)
- 5.2.3 Global Isosorbide Mononitrate Sales Volume Share by Application (2021-2032)
- 5.3 Global Isosorbide Mononitrate Sales Value by Application
- 5.3.1 Global Isosorbide Mononitrate Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Isosorbide Mononitrate Sales Value by Application (2021-2032)
- 5.3.3 Global Isosorbide Mononitrate Sales Value Share by Application (2021-2032)
6 Isosorbide Mononitrate Regional Sales and Value Analysis
- 6.1 Global Isosorbide Mononitrate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Isosorbide Mononitrate Sales by Region (2021-2032)
- 6.2.1 Global Isosorbide Mononitrate Sales by Region: 2021-2026
- 6.2.2 Global Isosorbide Mononitrate Sales by Region (2027-2032)
- 6.3 Global Isosorbide Mononitrate Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Isosorbide Mononitrate Sales Value by Region (2021-2032)
- 6.4.1 Global Isosorbide Mononitrate Sales Value by Region: 2021-2026
- 6.4.2 Global Isosorbide Mononitrate Sales Value by Region (2027-2032)
- 6.5 Global Isosorbide Mononitrate Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Isosorbide Mononitrate Sales Value (2021-2032)
- 6.6.2 North America Isosorbide Mononitrate Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Isosorbide Mononitrate Sales Value (2021-2032)
- 6.7.2 Europe Isosorbide Mononitrate Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Isosorbide Mononitrate Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Isosorbide Mononitrate Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Isosorbide Mononitrate Sales Value (2021-2032)
- 6.9.2 South America Isosorbide Mononitrate Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Isosorbide Mononitrate Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Isosorbide Mononitrate Sales Value Share by Country, 2025 VS 2032
7 Isosorbide Mononitrate Country-level Sales and Value Analysis
- 7.1 Global Isosorbide Mononitrate Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Isosorbide Mononitrate Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Isosorbide Mononitrate Sales by Country (2021-2032)
- 7.3.1 Global Isosorbide Mononitrate Sales by Country (2021-2026)
- 7.3.2 Global Isosorbide Mononitrate Sales by Country (2027-2032)
- 7.4 Global Isosorbide Mononitrate Sales Value by Country (2021-2032)
- 7.4.1 Global Isosorbide Mononitrate Sales Value by Country (2021-2026)
- 7.4.2 Global Isosorbide Mononitrate Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.9.2 France Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.16.2 China Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.19.2 India Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Isosorbide Mononitrate Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Isosorbide Mononitrate Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Isosorbide Mononitrate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Teva Isosorbide Mononitrate Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Shandong Fangming Pharmaceutical Group
- 8.2.1 Shandong Fangming Pharmaceutical Group Company Information
- 8.2.2 Shandong Fangming Pharmaceutical Group Business Overview
- 8.2.3 Shandong Fangming Pharmaceutical Group Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Shandong Fangming Pharmaceutical Group Isosorbide Mononitrate Product Portfolio
- 8.2.5 Shandong Fangming Pharmaceutical Group Recent Developments
- 8.3 Sandoz
- 8.3.1 Sandoz Company Information
- 8.3.2 Sandoz Business Overview
- 8.3.3 Sandoz Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Sandoz Isosorbide Mononitrate Product Portfolio
- 8.3.5 Sandoz Recent Developments
- 8.4 ReYoung Pharmaceutical
- 8.4.1 ReYoung Pharmaceutical Company Information
- 8.4.2 ReYoung Pharmaceutical Business Overview
- 8.4.3 ReYoung Pharmaceutical Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.4.4 ReYoung Pharmaceutical Isosorbide Mononitrate Product Portfolio
- 8.4.5 ReYoung Pharmaceutical Recent Developments
- 8.5 Merck
- 8.5.1 Merck Company Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Merck Isosorbide Mononitrate Product Portfolio
- 8.5.5 Merck Recent Developments
- 8.6 Taj pharmaceutical
- 8.6.1 Taj pharmaceutical Company Information
- 8.6.2 Taj pharmaceutical Business Overview
- 8.6.3 Taj pharmaceutical Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Taj pharmaceutical Isosorbide Mononitrate Product Portfolio
- 8.6.5 Taj pharmaceutical Recent Developments
- 8.7 Nesher Pharmaceuticals
- 8.7.1 Nesher Pharmaceuticals Company Information
- 8.7.2 Nesher Pharmaceuticals Business Overview
- 8.7.3 Nesher Pharmaceuticals Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Nesher Pharmaceuticals Isosorbide Mononitrate Product Portfolio
- 8.7.5 Nesher Pharmaceuticals Recent Developments
- 8.8 Intas Pharmaceuticals
- 8.8.1 Intas Pharmaceuticals Company Information
- 8.8.2 Intas Pharmaceuticals Business Overview
- 8.8.3 Intas Pharmaceuticals Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Intas Pharmaceuticals Isosorbide Mononitrate Product Portfolio
- 8.8.5 Intas Pharmaceuticals Recent Developments
- 8.9 Intas Pharmaceuticals
- 8.9.1 Intas Pharmaceuticals Company Information
- 8.9.2 Intas Pharmaceuticals Business Overview
- 8.9.3 Intas Pharmaceuticals Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Intas Pharmaceuticals Isosorbide Mononitrate Product Portfolio
- 8.9.5 Intas Pharmaceuticals Recent Developments
- 8.10 Globus Remedies
- 8.10.1 Globus Remedies Company Information
- 8.10.2 Globus Remedies Business Overview
- 8.10.3 Globus Remedies Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Globus Remedies Isosorbide Mononitrate Product Portfolio
- 8.10.5 Globus Remedies Recent Developments
- 8.11 AMRI
- 8.11.1 AMRI Company Information
- 8.11.2 AMRI Business Overview
- 8.11.3 AMRI Isosorbide Mononitrate Sales, Value and Gross Margin (2021-2026)
- 8.11.4 AMRI Isosorbide Mononitrate Product Portfolio
- 8.11.5 AMRI Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Isosorbide Mononitrate Value Chain Analysis
- 9.1.1 Isosorbide Mononitrate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Isosorbide Mononitrate Sales Mode & Process
- 9.2 Isosorbide Mononitrate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Isosorbide Mononitrate Distributors
- 9.2.3 Isosorbide Mononitrate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst